Exclusive Content
How does China’s patent linkage system affect biosimilar market entry for foreign firms?
How China's Patent Linkage System Affects Biosimilar Market Entry for Foreign Firms Since China formally implemented its patent linkage system (专利链接制度
What are the GCP requirements for running clinical trials in China as a foreign sponsor?
What Are the GCP Requirements for Running Clinical Trials in China as a Foreign Sponsor? What Are the GCP Requirements for Running Clinical Trials in
How to Navigate China’s Patent Linkage System for Biologics: 2026 Guide
How to Navigate China's Patent Linkage System for Biologics: 2026 Guide China's Patent Linkage System (药品专利链接制度, Drug Patent Linkage System, yàopǐn zh
How AstraZeneca Expanded Biologics Manufacturing in China Through Wuxi Biotech Park Incentives: A Case Study in Strategic Localization
How AstraZeneca Expanded Biologics Manufacturing in China Through Wuxi Biotech Park Incentives: A Case Study in Strategic Localization In 2022, AstraZ
How a US MedTech Startup Achieved NMPA Class II Medical Device Approval in 12 Months: China Case Study
How a US MedTech Startup Achieved NMPA Class II Medical Device Approval in 12 Months: China Case Study In under 12 months, a US-based digital health s
How Novartis Registered Kymriah (CAR-T) with NMPA in China
How Novartis Registered Kymriah (CAR-T) with NMPA in China | Cell Therapy Case Study body { font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-ser